Validating Automated Segmentation Tools in the Assessment of Caudate Atrophy in Huntington’s Disease
Background: Neuroimaging shows considerable promise in generating sensitive and objective outcome measures for therapeutic trials across a range of neurodegenerative conditions.
Nina M. Mansoor +10 more
doaj +1 more source
Exploring the structural relationship between interviewer and self-rated affective symptoms in Huntington’s disease [PDF]
This study explores the structural relationship between self-report and interview measures of affect in Huntington’s disease. The findings suggest continued use of both to recognize the multidimensionality within a single common consideration of ...
Dale M +8 more
core +3 more sources
Clinical and genetic analysis of 29 Brazilian patients with Huntington’s disease-like phenotype [PDF]
Huntington’s disease (HD) is a neurodegenerative disorder characterized by chorea, behavioral disturbances and dementia, caused by a pathological expansion of the CAG trinucleotide in the HTT gene. Several patients have been recognized with the typical
Lopes-Cendes, Iscia +31 more
core +1 more source
The personal experience of parenting a child with Juvenile Huntington’s Disease: perceptions across Europe [PDF]
The study reported here presents a detailed description of what it is like to parent a child with juvenile Huntington’s disease in families across four European countries. Its primary aim was to develop and extend findings from a previous UK study.
Jonathan A Smith +29 more
core +1 more source
Juvenile Onset Huntington's Disease [PDF]
The Special Issue “Juvenile Onset Huntington’s Disease” highlights the growing interest in understanding the unique aspects of this ultra-rare disorder.
core +1 more source
Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline [PDF]
Previous studies of the effects of coenzyme Q10 and minocycline on mouse models of Huntington’s disease have produced conflicting results regarding their efficacy in behavioral tests.
Brunner Daniela +38 more
core +1 more source
Predicting clinical scores in Huntington’s disease: a lightweight speech test [PDF]
OBJECTIVES: Using brief samples of speech recordings, we aimed at predicting, through machine learning, the clinical performance in Huntington’s Disease (HD), an inherited Neurodegenerative disease (NDD). METHODS: We collected and analyzed 126 samples of
Montillot, Justine +11 more
core +1 more source
22 Years of predictive testing for Huntington’s disease : the experience of the UK Huntington’s Prediction Consortium [PDF]
"22 Years of predictive testing for Huntington’s disease: the experience of the UK Huntington’s Prediction Consortium" European Journal of Human Genetics (2016) 24, 1515; doi:10.1038/ejhg.2016.81 Corrigendum: 15 September 2016 European Journal of Human ...
Quarrell, Oliver W +1 more
core +1 more source
Exploring the Reliability and Validity of the Huntington’s Disease Quality of Life Battery for Carers (HDQoL-C) within A Polish Population [PDF]
Huntington’s disease (HD) is a rare genetic neurodegenerative disorder that causes motor disorders, neuropsychiatric symptoms and a progressing deterioration of cognitive functions.
Aubeeluck, Aimee +16 more
core +2 more sources
Molecular Pathophysiological Mechanisms in Huntington’s Disease
Huntington’s disease is an inherited neurodegenerative disease described 150 years ago by George Huntington. The genetic defect was identified in 1993 to be an expanded CAG repeat on exon 1 of the huntingtin gene located on chromosome 4. In the following
Anamaria Jurcău
semanticscholar +1 more source

